Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275

كاردينال هيلث إنك

Cardinal Health, Inc.

CAH

0.00

Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE: CAH) with a Overweight and raises the price target from $258 to $275.